222 related articles for article (PubMed ID: 36161976)
1. Seroconversion rate after COVID-19 vaccination in patients with solid cancer: A systematic review and meta-analysis.
Yin J; Chen Y; Li Y; Zhang X; Wang C
Hum Vaccin Immunother; 2022 Nov; 18(6):2119763. PubMed ID: 36161976
[TBL] [Abstract][Full Text] [Related]
2. Immunogenicity and efficacy of COVID-19 vaccines in people living with HIV: a systematic review and meta-analysis.
Yin J; Chen Y; Li Y; Wang C; Zhang X
Int J Infect Dis; 2022 Nov; 124():212-223. PubMed ID: 36241168
[TBL] [Abstract][Full Text] [Related]
3. Immunogenicity and risk of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection after Coronavirus Disease 2019 (COVID-19) vaccination in patients with cancer: a systematic review and meta-analysis.
Becerril-Gaitan A; Vaca-Cartagena BF; Ferrigno AS; Mesa-Chavez F; Barrientos-Gutiérrez T; Tagliamento M; Lambertini M; Villarreal-Garza C
Eur J Cancer; 2022 Jan; 160():243-260. PubMed ID: 34794855
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of covid-19 vaccines in immunocompromised patients: systematic review and meta-analysis.
Lee ARYB; Wong SY; Chai LYA; Lee SC; Lee MX; Muthiah MD; Tay SH; Teo CB; Tan BKJ; Chan YH; Sundar R; Soon YY
BMJ; 2022 Mar; 376():e068632. PubMed ID: 35236664
[TBL] [Abstract][Full Text] [Related]
5. Seroconversion following the first, second, and third dose of SARS-CoV-2 vaccines in immunocompromised population: a systematic review and meta-analysis.
Mehrabi Nejad MM; Shobeiri P; Dehghanbanadaki H; Tabary M; Aryannejad A; Haji Ghadery A; Shabani M; Moosaie F; SeyedAlinaghi S; Rezaei N
Virol J; 2022 Aug; 19(1):132. PubMed ID: 35941646
[TBL] [Abstract][Full Text] [Related]
6. Immune response of COVID-19 vaccines in solid cancer patients: A meta-analysis.
Hua T; Fan R; Fan Y; Chen F
Hum Vaccin Immunother; 2024 Dec; 20(1):2357424. PubMed ID: 38785118
[TBL] [Abstract][Full Text] [Related]
7. Immunogenicity and safety of COVID-19 vaccines among people living with HIV: A systematic review and meta-analysis.
Zhao T; Yang Z; Wu Y; Yang J
Epidemiol Infect; 2023 Sep; 151():e176. PubMed ID: 37704371
[TBL] [Abstract][Full Text] [Related]
8. Seroconversion rate after vaccination against COVID-19 in patients with cancer-a systematic review.
Corti C; Antonarelli G; Scotté F; Spano JP; Barrière J; Michot JM; André F; Curigliano G
Ann Oncol; 2022 Feb; 33(2):158-168. PubMed ID: 34718117
[TBL] [Abstract][Full Text] [Related]
9. Determinants of humoral immune response to SARS-CoV-2 vaccines in solid cancer patients: A systematic review and meta-analysis.
Wankhede D; Grover S; Hofman P
Vaccine; 2023 Mar; 41(11):1791-1798. PubMed ID: 36792435
[TBL] [Abstract][Full Text] [Related]
10. COVID-19 vaccination in patients with cancer receiving immune checkpoint inhibitors: a systematic review and meta-analysis.
Ruiz JI; Lopez-Olivo MA; Geng Y; Suarez-Almazor ME
J Immunother Cancer; 2023 Feb; 11(2):. PubMed ID: 36746512
[TBL] [Abstract][Full Text] [Related]
11. Seroconversion rate after primary vaccination with two doses of BNT162b2 versus mRNA-1273 in solid organ transplant recipients: a systematic review and meta-analysis.
Verleye A; Wijtvliet V; Abrams S; Hellemans R; Bougrea R; Massart A; Pipeleers L; Wissing KM; Ariën KK; De Winter BY; Van Damme P; Abramowicz D; Ledeganck KJ
Nephrol Dial Transplant; 2022 Jul; 37(8):1566-1575. PubMed ID: 35544087
[TBL] [Abstract][Full Text] [Related]
12. Impact of Therapy in Patients with Hematologic Malignancies on Seroconversion Rates After SARS-CoV-2 Vaccination.
Guven DC; Sahin TK; Akın S; Uckun FM
Oncologist; 2022 Apr; 27(4):e357-e361. PubMed ID: 35274729
[TBL] [Abstract][Full Text] [Related]
13. COVID-19 Vaccination in Patients With Malignancy; A Systematic Review and Meta-Analysis of the Efficacy and Safety.
Javadinia SA; Alizadeh K; Mojadadi MS; Nikbakht F; Dashti F; Joudi M; Harati H; Welsh JS; Farahmand SA; Attarian F
Front Endocrinol (Lausanne); 2022; 13():860238. PubMed ID: 35586627
[TBL] [Abstract][Full Text] [Related]
14. Immunogenicity evaluation of ChAdox1 nCov-19 (AZD1222) vaccine in solid cancer patients in Chulabhorn Hospital.
Limpawittayakul P; Sungkasubun P; Chaiwiriyawong W; Supavavej A; Weerasubpong B; Siripaibun J; Phanthunane C; Lamlertthon W; Ungtrakul T; Tawinprai K; Tantiyavarong W; Samdaengpan C
Hum Vaccin Immunother; 2022 Nov; 18(6):2104058. PubMed ID: 35976687
[TBL] [Abstract][Full Text] [Related]
15. Immunogenicity of COVID-19 mRNA vaccines in hemodialysis patients: Systematic review and meta-analysis.
Falahi S; Sayyadi H; Kenarkoohi A
Health Sci Rep; 2022 Nov; 5(6):e874. PubMed ID: 36210877
[TBL] [Abstract][Full Text] [Related]
16. Solid cancer patients achieve adequate immunogenicity and low rate of severe adverse events after SARS-CoV-2 vaccination.
Janzic U; Bidovec-Stojkovic U; Mohorcic K; Mrak L; Dovnik NF; Ivanovic M; Ravnik M; Caks M; Skof E; Debeljak J; Korosec P; Rijavec M
Future Oncol; 2022 Jul; 18(23):2537-2550. PubMed ID: 35678621
[TBL] [Abstract][Full Text] [Related]
17. Immunogenicity of COVID-19 mRNA vaccines in immunocompromised patients: a systematic review and meta-analysis.
Mehrabi Nejad MM; Moosaie F; Dehghanbanadaki H; Haji Ghadery A; Shabani M; Tabary M; Aryannejad A; SeyedAlinaghi S; Rezaei N
Eur J Med Res; 2022 Feb; 27(1):23. PubMed ID: 35151362
[TBL] [Abstract][Full Text] [Related]
18. Effectiveness and Durability of COVID-19 Vaccination in 9447 Patients With IBD: A Systematic Review and Meta-Analysis.
Jena A; James D; Singh AK; Dutta U; Sebastian S; Sharma V
Clin Gastroenterol Hepatol; 2022 Jul; 20(7):1456-1479.e18. PubMed ID: 35189387
[TBL] [Abstract][Full Text] [Related]
19. Antibody response to a third booster dose of SARS-CoV-2 vaccination in adults with haematological and solid cancer: a systematic review.
Al Hajji Y; Taylor H; Starkey T; Lee LYW; Tilby M
Br J Cancer; 2022 Nov; 127(10):1827-1836. PubMed ID: 36224402
[TBL] [Abstract][Full Text] [Related]
20. Immunogenicity of COVID-19 vaccines in patients with cirrhosis: A meta-analysis.
Ouyang L; Lei G; Gong Y
Hum Vaccin Immunother; 2024 Dec; 20(1):2326316. PubMed ID: 38466197
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
